Inhibition of Chlamydia trachomatis replication in HEp-2 cells by human monocyte-derived macrophages
- PMID: 3182081
- PMCID: PMC259735
- DOI: 10.1128/iai.56.12.3280-3284.1988
Inhibition of Chlamydia trachomatis replication in HEp-2 cells by human monocyte-derived macrophages
Abstract
Monocytes (M) and macrophages are important components of the immune response to foreign agents. Using an in vitro system, we studied the influence of human M and M-derived macrophages (MdM) on the replication of Chlamydia trachomatis (L2/434) in HEp-2 cells. M or MdM were added to infected cells at a ratio of 4:1, and the resultant chlamydial yield was evaluated in one-step growth experiments. Chlamydial DNA production was evaluated by dot hybridization. Both M and MdM reduced chlamydial yield and DNA production, but the reductions caused by MdM were more pronounced. Electron microscopy showed that while control HEp-2 cells at 48 h postinfection contained large inclusions in which most particles were elementary bodies, the infected HEp-2 cells exposed to MdM contained small vacuoles with abnormal reticulate bodies and very few typical elementary bodies. Separation of the MdM from the HEp-2 cells by a membrane reduced the inhibitory effect of the MdM relative to that of MdM in direct contact with the infected cells. Addition of tumor necrosis factor antibodies to C. trachomatis-infected HEp-2 cells exposed to MdM (either in direct contact or separated by a membrane from the infected cells) reduced the inhibition of chlamydial DNA production. These data suggest the possibility that MdM may modulate C. trachomatis replication in vivo.
Similar articles
-
Implications for persistent chlamydial infections of phagocyte-microorganism interplay.Eur J Clin Microbiol Infect Dis. 1991 Feb;10(2):119-23. doi: 10.1007/BF01964423. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1907541 Review.
-
Differences in innate immune responses (in vitro) to HeLa cells infected with nondisseminating serovar E and disseminating serovar L2 of Chlamydia trachomatis.Infect Immun. 2002 Jun;70(6):3234-48. doi: 10.1128/IAI.70.6.3234-3248.2002. Infect Immun. 2002. PMID: 12011019 Free PMC article.
-
Fate of Chlamydia trachomatis in human monocytes and monocyte-derived macrophages.Infect Immun. 1986 Oct;54(1):90-5. doi: 10.1128/iai.54.1.90-95.1986. Infect Immun. 1986. PMID: 3759241 Free PMC article.
-
Inhibition of CMV replication in human fibroblasts by human monocyte-derived macrophages: implication for CMV persistent infection.Microb Pathog. 1988 Aug;5(2):97-107. doi: 10.1016/0882-4010(88)90012-5. Microb Pathog. 1988. PMID: 2853276
-
Production of Chlamydia trachomatis antigen and antiserum: a review.Scand J Infect Dis Suppl. 1982;32:30-3. Scand J Infect Dis Suppl. 1982. PMID: 6753132 Review.
Cited by
-
Implications for persistent chlamydial infections of phagocyte-microorganism interplay.Eur J Clin Microbiol Infect Dis. 1991 Feb;10(2):119-23. doi: 10.1007/BF01964423. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1907541 Review.
-
Interaction of chlamydiae and host cells in vitro.Microbiol Rev. 1991 Mar;55(1):143-90. doi: 10.1128/mr.55.1.143-190.1991. Microbiol Rev. 1991. PMID: 2030670 Free PMC article. Review.
-
Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon.Infect Immun. 1990 Jun;58(6):1886-90. doi: 10.1128/iai.58.6.1886-1890.1990. Infect Immun. 1990. PMID: 2111286 Free PMC article.
-
Differences in innate immune responses (in vitro) to HeLa cells infected with nondisseminating serovar E and disseminating serovar L2 of Chlamydia trachomatis.Infect Immun. 2002 Jun;70(6):3234-48. doi: 10.1128/IAI.70.6.3234-3248.2002. Infect Immun. 2002. PMID: 12011019 Free PMC article.
-
Does inhibition of tumor necrosis factor alpha affect chlamydial genital tract infection in mice and guinea pigs?Infect Immun. 2000 Sep;68(9):5299-305. doi: 10.1128/IAI.68.9.5299-5305.2000. Infect Immun. 2000. PMID: 10948158 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources